Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Recent patents describe new antidiabetic agents

July 18, 2007

Testosterone MD-Lotion elevates testosterone levels into normal healthy range

July 17, 2007

Diabetes incidence reduced in rheumatoid arthritis patients taking hydroxychloroquine

July 17, 2007

Selenium supplementation does not prevent type 2 diabetes

July 17, 2007

LifeCycle Pharma to begin phase II trial of LCP-AtorFen for high cholesterol

July 16, 2007

LAB reports positive interim results from phase II study of LAB GHRH

July 16, 2007

Amgen and Daiichi collaborate on development of denosumab in Japan

July 16, 2007

Tercica and Genentech to codevelop Nutropin AQ and Increlex combination drug

July 13, 2007

Novel therapeutic agents for obesity and lipoprotein disorders described in recent patents

July 13, 2007

Recent patents describe new treatment options for endocrine-related disorders

July 13, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...